These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

978 related articles for article (PubMed ID: 27189798)

  • 1. Cystic fibrosis.
    Ratjen F; Bell SC; Rowe SM; Goss CH; Quittner AL; Bush A
    Nat Rev Dis Primers; 2015 May; 1():15010. PubMed ID: 27189798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Therapies to Correct the Cystic Fibrosis Basic Defect.
    Bergeron C; Cantin AM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Patients with cystic fibrosis become adults : Treatment hopes and disappointments].
    Eschenhagen P; Schwarz C
    Internist (Berl); 2019 Jan; 60(1):98-108. PubMed ID: 30627755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapies in cystic fibrosis.
    Ratjen F; Grasemann H
    Curr Pharm Des; 2012; 18(5):614-27. PubMed ID: 22229570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis transmembrane conductance regulator (CFTR).
    Higgins CF
    Br Med Bull; 1992 Oct; 48(4):754-65. PubMed ID: 1281034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis transmembrane conductance regulator modulators: the end of the beginning.
    Barry PJ; Ronan N; Plant BJ
    Semin Respir Crit Care Med; 2015 Apr; 36(2):287-98. PubMed ID: 25826594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New treatments targeting the basic defects in cystic fibrosis.
    Fajac I; Wainwright CE
    Presse Med; 2017 Jun; 46(6 Pt 2):e165-e175. PubMed ID: 28554723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding how cystic fibrosis mutations cause a loss of Cl- channel function.
    Sheppard DN; Ostedgaard LS
    Mol Med Today; 1996 Jul; 2(7):290-7. PubMed ID: 8796909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cystic fibrosis based on understanding CFTR.
    Smith AE
    J Inherit Metab Dis; 1995; 18(4):508-16. PubMed ID: 7494409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of cystic fibrosis care: a global perspective.
    Bell SC; Mall MA; Gutierrez H; Macek M; Madge S; Davies JC; Burgel PR; Tullis E; Castaños C; Castellani C; Byrnes CA; Cathcart F; Chotirmall SH; Cosgriff R; Eichler I; Fajac I; Goss CH; Drevinek P; Farrell PM; Gravelle AM; Havermans T; Mayer-Hamblett N; Kashirskaya N; Kerem E; Mathew JL; McKone EF; Naehrlich L; Nasr SZ; Oates GR; O'Neill C; Pypops U; Raraigh KS; Rowe SM; Southern KW; Sivam S; Stephenson AL; Zampoli M; Ratjen F
    Lancet Respir Med; 2020 Jan; 8(1):65-124. PubMed ID: 31570318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of cystic fibrosis: CFTR mutation classifications toward genotype-based CF therapies.
    Fanen P; Wohlhuter-Haddad A; Hinzpeter A
    Int J Biochem Cell Biol; 2014 Jul; 52():94-102. PubMed ID: 24631642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cystic fibrosis: new treatments targeting the CFTR protein].
    Fajac I; Sermet-Gaudelus I
    Rev Mal Respir; 2013 Apr; 30(4):255-61. PubMed ID: 23664284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of cystic fibrosis treatment.
    Carter SC; McKone EF
    Pharmacogenomics; 2016 Aug; 17(13):1453-63. PubMed ID: 27490265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis: current concepts.
    Abrons HL
    W V Med J; 1993 Jun; 89(6):236-40. PubMed ID: 7686701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new era of personalized medicine for cystic fibrosis - at last!
    Quon BS; Wilcox PG
    Can Respir J; 2015; 22(5):257-60. PubMed ID: 26083544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cystic fibrosis lung disease and its management].
    Hidaka N; Hidaka Y
    Nihon Rinsho; 1999 Sep; 57(9):2139-44. PubMed ID: 10497420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ivacaftor: the first therapy acting on the primary cause of cystic fibrosis.
    McPhail GL; Clancy JP
    Drugs Today (Barc); 2013 Apr; 49(4):253-60. PubMed ID: 23616952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapy for cystic fibrosis: cystic fibrosis transmembrane conductance regulator mutation-specific pharmacologic strategies.
    Rubenstein RC
    Mol Diagn Ther; 2006; 10(5):293-301. PubMed ID: 17022692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CFTR protein and molecular mechanisms of pulmonary involvement in cystic fibrosis].
    Chinet T
    Rev Pneumol Clin; 1995; 51(3):122-9. PubMed ID: 7569573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of Cystic Fibrosis: Clinical Implications.
    Egan ME
    Clin Chest Med; 2016 Mar; 37(1):9-16. PubMed ID: 26857764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.